RHB Retail Research: Duopharma Biotech testing resistance

RHB Retail Research says Duopharma Biotech Berhad attempted to cross above the MYR1.67 resistance in the latest session.

In a trading note, the research house says an upside breach of this level, which coincides with the rising 21-day SMA line, could see the stock testing the MYR1.75 resistance, followed by MYR1.80.

“A stop-loss can be placed below MYR1.65,” it says.

LEAVE A REPLY

Please enter your comment!
Please enter your name here